Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Axsome Therapeutics Q2 Sales $87.166M Beat $86.659M Estimate

Author: Benzinga Newsdesk | August 05, 2024 07:01am
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly sales of $87.166 million which beat the analyst consensus estimate of $86.659 million by 0.58 percent. This is a 86.65 percent increase over sales of $46.700 million the same period last year.

Posted In: AXSM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist